About Us
- At A Glance
  Business Overview
  Timeline And History
  Global Operations Map
- Business Units
  API
  Antiretroviral (ARV)
  Overview
  Key facts about HIV/AIDS
  Products
  Global Partners
  Gallery
  Corporate Video
  AuroZymes
  Custom Synthesis
  Formulations
  Peptides
  R&D
- Corporate Governance
  Board Of Directors
  Board Committees
Sustainability
- ESG / Sustainability
  ESG Profile
  Sustainability Reports
  BMW Reports
- Social-Accountability-Standards
  Social Compliance Certification
  Sustainability Of Social Accountability Standards
  Human Rights Policy
  Progressive Health And Safety Practices
  Community Impact
  Supply Chain Management
  Supplier Code of Conduct
- CSR
  Our Commitment
  Annual Report
  Gallery
  Aurobindo Pharma Foundation
  Annual Action Plan
  Impact Assessment Reports - CSR Projects
- Access To Healthcare
  Pepfar program
Investors
- Results, Reports & Presentations
  Results Announcements
  Annual Reports
  Financials - Subsidiaries
  Related Party Transactions
- Shareholder Information
  Shareholding Pattern
  Buyback of shares
  Share Performance
  Financial Highlights
  Notice Of Board Meeting
  General Meetings
  Dividend Record
  Scheme Of Arrangements
  Unpaid Dividend Account Details
  Registrar And Share Transfer Agent
  Contact Details For Investor Grievance Redressal
  General
- Corporate Governance
  Board Of Directors
  Board Committees
  Governance Policies
  Code Of Conduct
  Code Of Practices And Procedures For Fair Disclosure
  Appointment And Resignation Of Directors
  Contact Details Of KMPs
  IR Contacts
- Disclosures Under Regulation 46
  Disclosures under Regulation 46 of the LODR
Media
- Press Releases
  - Corporate Announcements
- Media Kit
Careers
- HR Mission And Vision
- Current Vacancies
  - Searchable Database
Contact Us

DELIVERING ROBUST FINANCIALS

We believe that execution is everything
and always challenge ourselves to deliver superior performance

home
investors
shareholder information
shareholder structure

Shareholder Structure

Shareholding Pattern – 30.06.2024
Shareholding Pattern – 31.03.2024
Shareholding Pattern – 31.12.2023
Shareholding Pattern – 30.09.2023
Shareholding Pattern - 30.06.2023
Shareholding Pattern - 31.03.2023
Shareholding Pattern – 31.12.2022
Shareholding Pattern – 30.09.2022
Shareholding Pattern – 30.06.2022
Shareholding Pattern – 31.03.2022
Shareholding Pattern – 31.12.2021
Shareholding Pattern - 30.09.2021
Shareholding Pattern - 30.06.2021
Shareholding Pattern - 31.03.2021
Shareholding Pattern - 31.12.2020
Shareholding Pattern - 30.09.2020
Shareholding Pattern - 30.06.2020
Shareholding Pattern - 31.03.2020
Shareholding Pattern - 31.12.2019
Shareholding Pattern - 30.09.2019.
Shareholding Pattern - 30.06.2019.
Shareholding Pattern - 31.03.2019
Shareholding Pattern - 31.12.2018
Shareholding Pattern - 30.09.2018
Shareholding Pattern - 30.06.2018
Shareholding Pattern - 31.03.2018
Shareholding Pattern - 31.12.2017
Shareholding Pattern - 30.09.2017
Shareholding Pattern - 30.06.2017
Shareholding Pattern - 31.03.2017
Shareholding Pattern - 31.12.2016
Shareholding Pattern - 30.09.2016
Shareholding Pattern - 30.06.2016
Shareholding Pattern - 31.3.2016
Shareholding Pattern - 31.12.2015

© Copyright 2022 Aurobindo Pharma. All Rights Reserved.

Privacy Policy|Site Map

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. I Accept Cookie policy